# Hi-Great Group Holding Co > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Hi-Great Group Holding Co). ## Overview Hi-Great Group Holding Co is a development-stage U.S. holding company that has shifted away from CBD oils and is now focused on licensing and distributing niche consumer health products. Its current business plan centers on an exclusive worldwide license tied to the KRAS gene concept, the sale of SellaCare organic longevity supplements, and a planned expansion into cosmetics and herbal-based consumer products. ## Products & services • Exclusive worldwide license tied to KRAS gene-related business plan • SellaCare organic longevity health supplement • Plant-based finished consumer products • Specialty herb and herbal oil-based health products • Planned cosmetics-sector expansion • Agricultural and other sustainable business opportunities - **Health supplements** (70%) — Organic longevity and wellness supplements marketed under the SellaCare license. - **Licensing and IP-based initiatives** (10%) — Worldwide license arrangements and related commercialization concepts, including KRAS-related plans. - **Cosmetics and personal care** (10%) — Planned expansion into cosmetic products using herbal oils and compounds. - **Plant-based consumer products** (10%) — Finished consumer products built around specialty herbs and plant-based ingredients. - Exclusive worldwide license tied to KRAS gene-related business plan - SellaCare organic longevity health supplement - Plant-based finished consumer products - Specialty herb and herbal oil-based health products - Planned cosmetics-sector expansion - Agricultural and other sustainable business opportunities ## Customers The company appears to sell to consumers seeking longevity, wellness, and herbal supplement products, with a planned extension into cosmetics buyers. Its licensing and product-distribution model suggests demand is driven by end users interested in niche health claims, natural ingredients, and alternative wellness positioning. - **Wellness supplement consumers** (primary) — Buy SellaCare longevity supplements for perceived health and longevity benefits. - **Natural and organic product buyers** (primary) — Purchase plant-based and specialty-herb products because they prefer natural ingredients. - **Cosmetics and personal care consumers** (emerging) — Would buy herbal-oil and compound-based cosmetic products as the company expands. - **Commercial license and distribution partners** (secondary) — Support product access, branding, and market reach through licensing or distribution arrangements. - Consumers buying longevity and wellness supplements - Customers seeking organic or plant-based health products - Potential cosmetics buyers interested in herbal formulations - Partners and distributors supporting product commercialization - License counterparties tied to IP and brand usage ## Geography The company is incorporated in Nevada and appears to operate primarily from the United States, with no disclosed country-by-country revenue split. Its business plan references a worldwide license and global commercialization ambitions, so future exposure could extend beyond the U.S. if product distribution scales. - Incorporated in Nevada, United States - Current operations appear U.S.-based - Worldwide license language suggests global commercialization intent - No disclosed country revenue breakdown in the excerpts - Geographic expansion would increase regulatory and distribution complexity ## Strategy Management is trying to reposition the company around licensed wellness products, herbal consumer goods, and a future cosmetics platform after withdrawing CBD oils from the plan. The strategy depends on turning small-scale sales into a sustainable revenue base while preserving optionality across multiple consumer-health categories. - **Commercialize licensed wellness products** (short-term) — The company needs a clearer revenue engine than its prior CBD-related plan. - **Expand into cosmetics** (medium-term) — Cosmetics could broaden the addressable market and diversify product risk. - **Build a sustainable multi-category platform** (medium-term) — Management wants multiple revenue streams to reduce dependence on one product line. - Shift away from CBD oils and into other wellness categories - Commercialize the SellaCare longevity supplement license - Expand into cosmetics using herbal oils and compounds - Use plant-based consumer products to build recurring revenue - Pursue additional agricultural or sustainable opportunities ## Risks The company remains development-stage, with very limited sales and recurring losses, so execution and financing risk are central. Its product plan also depends on licensing, regulatory acceptance, and consumer demand for wellness and cosmetic claims, which can be difficult to sustain in a small-cap business. - **Liquidity and going-concern pressure** [high] — The company has an accumulated deficit and small operating cash flows, so it may need external funding to continue. - **Commercialization failure** [high] — The business model depends on turning licensing and niche products into meaningful sales, which may not happen. - **Regulatory and product-claim risk** [medium] — Supplements and cosmetics can face scrutiny over marketing claims, ingredients, and compliance. - **Dependence on third-party arrangements** [medium] — The company relies on licenses, vendors, and service providers to execute its plan. - Development-stage business with limited operating scale - Recurring losses and accumulated deficit pressure liquidity - Dependence on future financing to fund operations - Regulatory and claim-risk in supplements and cosmetics - Commercialization risk around licensed IP and product rollout - General consumer demand and macroeconomic sensitivity ## Accounting The company’s reported results are shaped by a very small revenue base, so modest changes in sales and expenses can swing losses materially. Investors should watch how management accounts for licensing arrangements, vendor equity issuances, and any future estimates or contingencies, because these items can affect both the income statement and equity. - **Revenue recognition on product sales and licenses** — Can shift revenue between periods and affect comparability - **Equity issued for services** — Affects operating expenses and shareholders' equity - **Contingencies and estimates** — Can change liabilities, expenses, and net loss - Small revenue base makes quarterly comparisons volatile - Vendor shares issued for services affect equity and expense recognition - Licensing arrangements may require judgment on revenue timing - Estimates and contingencies can materially affect reported losses - Loss carryforwards and accumulated deficit matter for future reporting --- *Last updated: 2026-04-28T20:14:46.834019+00:00*